Skip to content

Syntheon LLC is a Miami-based medical device incubator founded in 1999 that invents and develops innovative medical devices.

Last updated September 16, 2026

AI crawler reads

2requests

1companies
  • Anthropic2
Profile
2
Controversies
0
JSON · MD
0
First read
Nov 4, 2026
Latest read
Nov 4, 2026

From this site's server log

Overview

Syntheon LLC is a medical device incubator based in Miami, Florida, founded in 1999. The company invents and develops innovative medical devices, leveraging over 200 issued patents and 100 years of product development experience among its principals. It works both by developing patented devices through subsidiary entities and by partnering with medical device companies to develop new products from initial innovation through final manufacturing. Its proprietary technologies have been acquired by companies such as Johnson & Johnson, Boston Scientific, Edwards and Olympus.

History

Syntheon LLC was founded in 1999 and is described as a well-known medical device incubator. The principals of Syntheon have over 200 issued patents and 100 years of product development experience, with a long list of products that have improved medical care and increased value to partnering companies' shareholders. The company uses two approaches: in all cases, it leverages its experience to solve difficult problems with innovative and elegant electro-mechanical devices, using rapid prototyping and testing to create patented and competitive products ready for clinical trials, manufacture or deployment through subsidiary entities; in select cases, it works with medical device companies that have identified a market need, developing a new product from initial innovation through final manufacturing in close partnership, sharing in both risk and reward. Many of the industry's most trusted and admired companies, such as Johnson & Johnson, Boston Scientific, Edwards and Olympus, have acquired Syntheon's proprietary technologies.

Products and positioning

Innovative medical device incubator meeting large market, unmet needs with patented devices – from design to manufacturing.

Recent events

  • Reported

    RapidPulse closes $15 million Series A financing[3]

    RapidPulse announced the closing of a $15 million Series A financing led by Santé Ventures, with Epidarex Capital, Hatteras Venture Partners, Broadview Ventures, and Syntheon participating.

Read more

Sources3 sources

Cite this profile: Cite the canonical profile. /brand-wiki/syntheon-united-states · Editorial policy · How profiles are compiled